Discover
ABBV
AbbVie Inc.
251.06
100 x undefined
300 x undefined
bid
ask
-
0.58
0.23%
200 @ 06:00 AM
251.71 +0.65 (0.26%)
| Ytd | 9.88% | |
| 1y | 32.14% |
247.59
day range
251.80
184.63
52 week range
255.99
| Open | 250.75 | Prev Close | 251.64 | Low | 247.59 | High | 251.80 | Mkt Cap | 443.57B |
| Vol | 6.68M | Avg Vol | 7.07M | EPS | 2.03 | P/E | 123.67 | Forward P/E | 15.44 |
| Beta | 0.31 | Short Ratio | 4.46 | Inst. Own | 76.80% | Dividend | 6.92 | Div Yield | 2.75 |
| Ex Div Date | 07-15 | Earning | 07-31 | 50-d Avg | 217.50 | 200-d Avg | 221.79 | 1yr Est | 254.38 |
| Income Statement | |||
| Total Revenue | 15.00B | ||
| Revenues (USD) | 15.00B | ||
| Cost of Revenue | 4.22B | ||
| Gross Profit | 10.78B | ||
| Operating Expenses | 6.79B | ||
| Research and Development Expense | 2.47B | ||
| Selling, General and Administrative Expense | 3.58B | ||
| Operating Income | 3.99B | ||
| Interest Expense | 645.00M | ||
| Income Tax Expense | 342.00M | ||
| Net Income | 695.00M | ||
| Net Income Common Stock | 695.00M | ||
| Net Income Common Stock (USD) | 695.00M | ||
| Consolidated Income | 697.00M | ||
| Net Income to Non-Controlling Interests | 2.00M | ||
| Earnings per Basic Share | 0.39 | ||
| Earnings per Basic Share (USD) | 0.39 | ||
| Earnings per Diluted Share | 0.39 | ||
| Dividends per Basic Common Share | 1.73 | ||
| Earning Before Interest & Taxes (EBIT) | 1.68B | ||
| Earning Before Interest & Taxes (USD) | 1.68B | ||
| Weighted Average Shares | 1.77B | ||
| Weighted Average Shares Diluted | 1.77B | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.39B | ||
| Cash and Equivalents (USD) | 9.39B | ||
| Investments | 268.00M | ||
| Investments Non-Current | 268.00M | ||
| Trade and Non-Trade Receivables | 12.48B | ||
| Current Assets | 33.53B | ||
| Property, Plant & Equipment Net | 5.69B | ||
| Total Assets | 136.46B | ||
| Debt Current | 8.33B | ||
| Total Debt | 72.86B | ||
| Current Liabilities | 42.10B | ||
| Debt Non-Current | 64.53B | ||
| Total Liabilities | 143.12B | ||
| Accumulated Retained Earnings (Deficit) | -17.87B | ||
| Accumulated Other Comprehensive Income | -1.15B | ||
| Shareholders Equity | -6.70B | ||
| Shareholders Equity (USD) | -6.70B | ||
| Assets Non-Current | 102.93B | ||
| Total Debt (USD) | 72.86B | ||
| Goodwill and Intangible Assets | 86.44B | ||
| Inventory | 5.05B | ||
| Liabilities Non-Current | 101.02B | ||
| Trade and Non-Trade Payables | 33.77B | ||
| Tax Liabilities | 2.33B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.94B | ||
| Net Cash Flow from Financing | 919.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.16B | ||
| Capital Expenditure | -265.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -266.00M | ||
| Issuance (Purchase) of Equity Shares | -1.49B | ||
| Issuance (Repayment) of Debt Securities | 5.49B | ||
| Payment of Dividends & Other Cash Distributions | -3.09B | ||
| Net Cash Flow from Investing | -574.00M | ||
| Net Cash Flow from Operations | 3.83B | ||
| Effect of Exchange Rate Changes on Cash | -12.00M | ||
| Share Based Compensation | 444.00M | ||